Specifications tableSubjectHuman targeted genome sequencingSpecific subject areaGenomicsType of dataGenome sequences (Targeted DNA-Seq raw reads)Data retrievalIllumina NextSeq 500 sequencing platformData formatRaw sequences (FASTQ)Parameters for data collectionDNA was extracted from the buffy coat of whole blood sample and was quantified, followed by preparation and quality check of the DNA libraries.Description of data collectionDNA was extracted using QIAamp DNA Mini Kit® (Qiagen Sciences, Germantown, Maryland). Double-stranded DNA concentration was quantified with a Qubit® 3.0 Fluorometer (Thermo Fisher Scientific, Waltham, MA, USA) using Qubit dsDNA BR Assay Kit (Thermo Fisher Scientific). Libraries were prepared using TargetRich™ Hereditary Cancer Panel (Kailos Genetics®, Huntsville, AL, United States). Sequencing was performed using Illumina NextSeq 500 system.Data source locationFaculty of Medicine, Universitas Indonesia, Jakarta, IndonesiaData accessibilityRaw data (FASTQ) files have been deposited to National Center for Biotechnology Information (NCBI), <https://www.ncbi.nlm.nih.gov/>, under BioProject database: <https://www.ncbi.nlm.nih.gov/bioproject/606794>, BioSample database: <https://www.ncbi.nlm.nih.gov/biosample?Db=biosample&DbFrom=bioproject&Cmd=Link&LinkName=bioproject_biosample&LinkReadableName=BioSample&ordinalpos=1&IdsFromResult=606794> and SRA database: with accession number: SRR11774092--SRR11774115 (<https://www.ncbi.nlm.nih.gov/sra?linkname=bioproject_sra_all&from_uid=606794>).

Importance of the data•Provides information about breast cancer related genes•Provides novel insights regarding breast cancer development to clinicians and subjects•Helps to reduce morbidity and mortality via targeted risk management options

1. Data description {#sec0001}
===================

Cancer is associated with the accumulation of various somatic mutations, structural variants, epigenetic factors, and copy number alterations that occur in a pre-disposed genetic background including hereditary cancers. Advances in sequencing technologies and computational tool development have enabled the implementation of whole‐genome sequencing (WGS) in routine clinical settings, thereby supporting the clinical relevance of genomics with cancer medicine. Precision oncology is a novel approach that directs the clinician to the targeted drug, which is presumed to be effective, after examining the tumour and patient genomes [@bib0001].

In this study, we present the data of targeted genome sequence from 24 young women breast cancer patients admitted to Cipto Mangunkusumo National Hospital, Jakarta. Concentration of double-stranded DNA was quantified using Qubit 3.0 ([Table 1](#tbl0001){ref-type="table"}). Library preparations were set-up using TargetRich™ Hereditary Cancer Panel (Kailos Genetics®). The sequencing process was carried out using Illumina NextSeq 500 and produced 2 × 150 bp paired-end libraries from the sequencing runs ([Table 2](#tbl0002){ref-type="table"}).Table 1Double-stranded DNA concentration.Table 1SampleQubit 3.0 (C) (μg/mL)BRCA_35_CMNH_1745.1BRCA_36_CMNH_1752BRCA_38_CMNH_1742.7BRCA_39_CMNH_1751.6BRCA_41_CMNH_1744BRCA_42_CMNH_1739.3BRCA_44_CMNH_1747.2BRCA_45_CMNH_1756.9BRCA_46_CMNH_1746.4BRCA_48_CMNH_1753.1BRCA_49_CMNH_1750.3BRCA_50_CMNH_1740.5BRCA_52_CMNH_1735.7BRCA_62_CMNH_1753.6BRCA_63_CMNH_1748.6BRCA_65_CMNH_1747.3BRCA_66_CMNH_1752.2BRCA_67_CMNH_1757.6BRCA_68_CMNH_1747BRCA_70_CMNH_1741.8BRCA_71_CMNH_1737.3BRCA_72_CMNH_1747.6BRCA_73_CMNH_1752.4BRCA_75_CMNH_1751Table 2Descriptive information of raw sequencing data for targeted genome sequencing.Table 2SampleBioSample accession numberSRA accession numberTotal raw readsTotal raw bases (base-pairs)Q30 (%)GC content (%)BRCA_35_CMNH_17SAMN14883639SRR117740941,335,991377,349,41790.039.3BRCA_36_CMNH_17SAMN14883641SRR117740931,359,247389,345,33287.540.0BRCA_38_CMNH_17SAMN14883672SRR117741061,270,966365,237,86386.240.3BRCA_39_CMNH_17SAMN14883913SRR117741011,646,642473,677,41186.740.0BRCA_41_CMNH_17SAMN14883916SRR117741001,443,000415,153,36486.540.0BRCA_42_CMNH_17SAMN14883929SRR117740991,346,075380,618,49190.239.0BRCA_44_CMNH_17SAMN14883930SRR117740981,316,741371,918,89190.040.0BRCA_45_CMNH_17SAMN14883931SRR117740971,410,307405,715,60387.140.0BRCA_46_CMNH_17SAMN14883935SRR117740961,391,837385,392,11279.240.0BRCA_48_CMNH_17SAMN14883936SRR117740951,283,974367,644,57274.440.5BRCA_49_CMNH_17SAMN14883938SRR117740922,073,069560,176,78677.340.1BRCA_50_CMNH_17SAMN14883940SRR117741151,392,202400,365,00687.040.0BRCA_52_CMNH_17SAMN14883941SRR117741141,885,957542,180,05176.940.0BRCA_62_CMNH_17SAMN14883942SRR117741131,952,838540,506,65782.540.0BRCA_63_CMNH_17SAMN14883946SRR117741121,399,969394,781,35489.540.0BRCA_65_CMNH_17SAMN14883947SRR117741111,349,591381,316,42190.239.4BRCA_66_CMNH_17SAMN14883948SRR117741101,437,684413,474,94186.840.0BRCA_67_CMNH_17SAMN14883949SRR117741091,339,951385,231,90887.140.0BRCA_68_CMNH_17SAMN14883950SRR117741081,407,335397,527,46089.939.4BRCA_70_CMNH_17SAMN14883951SRR117741071,361,857385,023,78490.240.0BRCA_71_CMNH_17SAMN14883968SRR117741051,522,138436,958,49186.340.9BRCA_72_CMNH_17SAMN14883969SRR117741041,327,112381,359,34286.140.9BRCA_73_CMNH_17SAMN14883970SRR117741032,133,736613,933,79786.840.0BRCA_75_CMNH_17SAMN14883971SRR117741021,478,419425,334,04186.540.0

FASTQ raw data files have been deposited to the NCBI database under BioProject database: PRJNA606794 (<https://www.ncbi.nlm.nih.gov/bioproject/?term=PRJNA606794>), BioSample database: <https://www.ncbi.nlm.nih.gov/biosample?Db=biosample&DbFrom=bioproject&Cmd=Link&LinkName=bioproject_biosample&LinkReadableName=BioSample&ordinalpos=1&IdsFromResult=606794>, and Sequence Read Archive (SRA) accession numbers: SRR11774092--SRR11774115. These data will be useful in analysing the genome markers in breast cancer, and could predict the effective treatments related to their mutation. Methods of sample collection, DNA isolation, library preparation, and sequencing are presented in the following section.

2. Experimental design, materials and methods {#sec0002}
=============================================

2.1. Sample collection and DNA isolation {#sec0003}
----------------------------------------

Blood samples were collected from 24 young women breast cancer patients. Purified DNA was extracted from the blood buffy coat (it has been recommended to use buffy coat fragments as DNA source [@bib0002]) using reagents from the QIAamp DNA Mini Kit® (Qiagen Sciences), as per the manufacturer\'s recommendation. Double-stranded DNA concentration was quantified using Qubit® 3.0 Fluorometer (Thermo Fisher Scientific) using Qubit dsDNA BR Assay Kit (Thermo Fisher Scientific). [Table 1](#tbl0001){ref-type="table"} provides information regarding the concentration of double-stranded DNA of the isolates.

2.2. Library preparation {#sec0004}
------------------------

DNA libraries were prepared using TargetRich™ Hereditary Cancer Panel (Kailos Genetics®, Huntsville, AL, United States). Moreover, we used TargetRich™ UMI/Index Adapter Plate (Kailos Genetics®) in patch ligation step. The libraries construction included following steps:1)Annealing of guide oligonucleotides and restriction digestAbout 100 ng of each genomic DNA sample was used as an input and mixed with nuclease-free water and Annealing-Digest Master Mix. The samples were centrifuged briefly to collect the entire liquid at the bottom of the tubes. Thereafter, restriction enzyme was added to each solution and digestion was performed using Thermal Cycler.2)Patch ligationTargetRich™ UMI/Index Adapter Plate was added into the aforementioned solution, and DNA ligase was added to each sample. Thermal cycler was used to complete the process.3)Enzymatic clean-upEnzymatic Clean-up Master Mix was used to clean the chemical waste from the product used in previous steps.4)On-bead purificationAMPure® XP beads were used for DNA purification and were added to the mix solution. The cleared solution was discarded, and freshly prepared 70% ethanol was added to it. Without disturbing the beads, ethanol was removed and the beads were air-dried to remove all the traces of ethanol. The DNA on beads was separated by re-suspending the beads in nuclease-free water.5)PCR amplificationThe barcoded-DNA was amplified using combination of Universal PCR Master Mix and DNA polymerase on Thermal Cycler.6)On-bead purificationThe DNA libraries were purified using AMPure® XP beads to remove the chemical waste from the products used in the previous steps [@bib0003].

2.3. Targeted genome sequencing and data {#sec0005}
----------------------------------------

The DNA libraries were mixed with TargetRich™ UMI/Index Adapter Plate (Kailos Genetics®, Huntsville, AL, United States) for sample barcoding, multiplex sequencing, and tagging of individual captured DNA molecules. The barcoded DNA libraries were sequenced using Illumina NextSeq 500 platform, according to the following steps: 1) preparing the library/PhiX mix; 2) denaturing the library/PhiX mix; 3) diluting the denaturated library/PhiX mix with HT-1 buffer; 4) loading the libraries onto NextSeq 500 reagent cartridge and 5) setting up the sequencing run [@bib0004], [@bib0005]. The sequencing run produced 2 × 150 bp paired-end libraries ([Table 2](#tbl0002){ref-type="table"}). The data sequences were deposited to the SRA under the BioProject accession number PRJNA606794. Total raw reads were obtained using FastQC software [@bib0006], and the total raw bases and percentage of Q30 were evaluated using q30 python scripts. [@bib0007]
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